Light Mode
$16.07 ↓ -0.56 (-3.40%) Trading Down from the previous close of $16.63
-8.18 (-32.97%) / 6M
Momentum, market sentiment, and recent alerts
RARE reads not so good: price sits above one of the two key moving averages, the 12-month move is -48.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.